Seeing Is Believing
Currently out of the existing stock ratings of Georgi Yordanov, 5 are a BUY (83.33%), 1 are a HOLD (16.67%).
Analyst Georgi Yordanov, currently employed carries an average stock price target met ratio of 16.67% that have a potential upside of 21.51% achieved within 389 days.
Georgi Yordanov’s has documented 12 price targets and ratings displayed on 1 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on NVAX, Novavax at 20-Apr-2023.
Analyst best performing recommendations are on NVAX (NOVAVAX).
The best stock recommendation documented was for NVAX (NOVAVAX) at 4/20/2023. The price target of $10 was fulfilled within 389 days with a profit of $1.77 (21.51%) receiving and performance score of 0.55.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$19
$11.68 (159.56%)
$19
8 days ago
(13-Nov-2024)
15/23 (65.22%)
$10.49 (123.27%)
161
Buy
$26
$18.68 (255.19%)
$23
1 months 11 days ago
(10-Oct-2024)
16/41 (39.02%)
$13.09 (101.39%)
85
Sell
$9
$1.68 (22.95%)
$8
3 months 9 days ago
(12-Aug-2024)
7/9 (77.78%)
$-2.85 (-24.05%)
61
Hold
$18
$10.68 (145.90%)
$13
5 months 7 days ago
(14-Jun-2024)
3/4 (75%)
$3.6 (25.00%)
228
Hold
$10
$2.68 (36.61%)
$110
1 years 7 months 1 days ago
(20-Apr-2023)
1/6 (16.67%)
$1.77 (21.51%)
389
What Year was the first public recommendation made by Georgi Yordanov?